Federal Register Notice: FDA is making available a draft guidance for industry, Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims. It is intended to assist applicants in developing labeling for cardiovascular outcome claims for drugs that are indicated to treat hypertension. To download this guidance, click here. To view this notice, click here.
